Last update 26 May 2025

GH-2616

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
GH2616
Target
KIF18A
Action
inhibitors
Mechanism
KIF18A inhibitors(kinesin family member 18A inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmNeoplasms
Inactive Indication-
Originator Organization
Qinhao Pharmaceutical (Suzhou) Co., Ltd.Qinhao Pharmaceutical (Suzhou) Co., Ltd.
Active Organization
Qinhao Pharmaceutical (Suzhou) Co., Ltd.Qinhao Pharmaceutical (Suzhou) Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with GH-2616
NCT06329206
/ RecruitingPhase 1
A Phase Ia/Ib Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of GH2616 Tablet in Subjects With Advanced Solid Tumors
CTR20244914
/ Not yet recruitingPhase 1
一项评价GH2616片在晚期实体瘤受试者中的安全性、耐受性、药代动力学和初步疗效的I期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of GH2616 tablets in subjects with advanced solid tumors
100 Clinical Results associated with GH-2616
Login to view more data
100 Translational Medicine associated with GH-2616
Login to view more data
100 Patents (Medical) associated with GH-2616
Login to view more data
100 Deals associated with GH-2616
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Qinhao Pharmaceutical (Suzhou) Co., Ltd.Qinhao Pharmaceutical (Suzhou) Co., Ltd.
13 Mar 2024
NeoplasmsIND Application
United States
Qinhao Pharmaceutical (Suzhou) Co., Ltd.Qinhao Pharmaceutical (Suzhou) Co., Ltd.
11 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free